They found that the NFKBIA rs696 site was linked with the susceptibility of cardia cancer while NFKBIA rs2233406 mutation was associated with the susceptibility of non-cardia cancer, with heterozygous mutations increasing the risk of non-cardia cancer. Here, NFKBIA is linked to cardia cancer.